AULSF 财务： Austar Lifesciences Ltd AI 分析

主页

股票

AULSF

财务数据

AULSF 财务

Austar Lifesciences Ltd

$0.07

收盘价：Mar 30, 16:00:00 GMT-4

$0.07

盘后：Mar 30, 20:00:00 GMT-4

概述预测收益股息财务数据

收入

资产负债表

现金流量

年度

季度性

AULSF 收入

以百万美元为单位的财务数据。财年为2月至次年1月。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
营收	1,461	1,500	1,763	2,156	2,015	1,295
营收同比增长 (YoY)	-3%	-15%	-18%	7%	56%	23%
营收成本	1,166	1,199	1,427	1,668	1,536	972
毛利润	294	301	336	488	479	323
销售、一般及管理费用	238	233	327	299	300	255
研发	46	53	55	70	65	48
营业费用	256	262	377	366	361	296
其他非经营性收入 (费用)	--	--	--	--	--	--
税前利润	42	21	-34	119	319	41
所得税费用	9	7	0	18	46	9
净利润	35	16	-113	87	277	33
净利润增长	-152%	-113.99%	-229.99%	-69%	739%	313%
稀释后流通股数	512.58	512.58	512.58	512.58	512.58	512.58
股份同比变动 (YoY)	0%	0%	0%	0%	0%	0%
每股收益 (摊薄)	0.06	0.03	-0.22	0.17	0.54	0.06
每股收益增长率	-153%	-113.99%	-229%	-69%	737%	309%
自由现金流	--	78	-131	-155	-204	25
每股自由现金流	--	--	--	--	--	--
毛利率	20.12%	20.06%	19.05%	22.63%	23.77%	24.94%
营业利润率	2.53%	2.53%	-2.32%	5.65%	5.8%	2%
净利率	2.39%	1.06%	-6.4%	4.03%	13.74%	2.54%
自由现金流利润率	--	5.2%	-7.43%	-7.18%	-10.12%	1.93%
EBITDA	--	43	-36	125	120	29
EBITDA 利润率	--	2.86%	-2.04%	5.79%	5.95%	2.23%
EBITDA 中的折旧与摊销	--	5	5	3	3	3
EBIT	37	38	-41	122	117	26
EBIT 利润率	2.53%	2.53%	-2.32%	5.65%	5.8%	2%
有效税率	21.42%	33.33%	0%	15.12%	14.42%	21.95%

Follow-Up Questions

Austar Lifesciences Ltd 的关键财务报表是什么？



根据最新的财务报表（Form-10K），Austar Lifesciences Ltd 的总资产为 $2,083，净利润为 $16

AULSF 的关键财务比率是什么？



Austar Lifesciences Ltd 的流动比率是 1.61，净利 margin 为 1.06，每股销售为 $2.92。

Austar Lifesciences Ltd 的收入按细分市场或地理位置如何划分？



Austar Lifesciences Ltd 最大收入来源是 Integrated Process and Packaging Equipment & Systems，在最近的收益报告中收入为 710,388,913。就地区而言， China 是 Austar Lifesciences Ltd 的主要市场，收入为 1,445,798,461。

Austar Lifesciences Ltd 是否盈利？



是的，根据最新的财务报表，Austar Lifesciences Ltd 的净利润为 $16

Austar Lifesciences Ltd 有负债吗？



是的，Austar Lifesciences Ltd 的负债为 1,292

Austar Lifesciences Ltd 的流通股有多少？



Austar Lifesciences Ltd 的总流通股为 512.58

关键数据

前收盘价

$0.07

开盘价

$0.005

当日区间

$0.005 - $0.07

52周范围

$0.005 - $0.07

交易量

250

平均成交量

股息收益率

每股收益（TTM）

0.00

市值

$35.8M

什么是 AUSTAR LIFESCIENCE LIMITED？

Austar Lifesciences Ltd. is an investment holding company, which engages in the provision of engineering solutions to pharmaceutical manufacturers and research institutes. The company is headquartered in Shanghai, Shanghai and currently employs 1,446 full-time employees. The company went IPO on 2014-11-07. The firm operates three segments. The Integrated Process and Packaging Equipment & Systems segment mainly includes liquid process systems and powder-solid systems. The Consulting, Digitalization and Construction segment mainly includes design consulting, compliance service systems, as well as cleanroom and automation control systems. The Life Science Equipment and Consumables segment focuses on life science and technology consumables, advanced treatment and advanced bioprocess technologies.

功能特性

资源